Enteral tube feeding for cystic fibrosis

Enteral tube feeding for individuals with cystic fibrosis: Cystic Fibrosis Foundation evidence-informed guidelines

“…There are no randomized clinical trials to inform decisions regarding enteral tube feeding and CF, however, multiple retrospective studies suggest that its use can improve agedependent anthropometrics [7][8][9][10][11][12][13][14][15][16][17][18]20]. Age-dependent anthropometrics include weight/age percentile, length/age percentile and weight-for-length percentile for 0-2 years; weight/age percentile, stature/age percentile and body mass index (BMI) percentile for 2-20 years; and BMI value for adults [21][22][23].…”

Enteral tube feeding for individuals with cystic fibrosis: Cystic Fibrosis Foundation evidence-informed guidelines

“…There are no randomized clinical trials to inform decisions regarding enteral tube feeding and CF, however, multiple retrospective studies suggest that its use can improve agedependent anthropometrics [7][8][9][10][11][12][13][14][15][16][17][18]20]. Age-dependent anthropometrics include weight/age percentile, length/age percentile and weight-for-length percentile for 0-2 years; weight/age percentile, stature/age percentile and body mass index (BMI) percentile for 2-20 years; and BMI value for adults [21][22][23].…”

Evolución nutricional y función pulmonar en niños y adolescentes chilenos con fibrosis quística

“…Dicha recomendación se basa en que sobre p50 de IMC, el VEF 1 presenta un plateau superior a 80% y bajo p50 se deteriora, con mayor pendiente bajo p10 3 . Para adelantarse, se recomienda apoyo nutricional precoz y activo 10,11,24 , siendo importante explicar el défi cit y acordar con el paciente y su familia los plazos de respuesta, ya que en etapas avanzadas de la enfermedad se suman otros factores difíciles de revertir, los cuales agravan el deterioro pulmonar [25][26][27] . En adultos, se recomienda mantener un IMC mayor a 22 en mujeres y a 23 en hombres, puntos de corte asociados a un VEF 1  60% del predicho 11 .…”

Description of a Standardized Nutrition Classification Plan and its Relation to Nutritional Outcomes in Children with Cystic Fibrosis

“…However, these supplements have not been shown to consistently improve nutritional outcomes, especially when compared to behavioral interventions (Koretz, Avenell, Lipman, Braunschweig, & Milne, 2007;Smyth & Walters, 2007). Additionally, there are no randomized control trials to support the use of enteral feeding tubes in CF patients (Conway, Morton, & Wolfe, 2008). Appetite stimulants are also widely prescribed, but there are no large trials confirming their usefulness.…”

Enteral tube feeding for individuals with cystic fibrosis: Cystic Fibrosis Foundation evidence-informed guidelines

“…There are no randomized clinical trials to inform decisions regarding enteral tube feeding and CF, however, multiple retrospective studies suggest that its use can improve agedependent anthropometrics [7][8][9][10][11][12][13][14][15][16][17][18]20]. Age-dependent anthropometrics include weight/age percentile, length/age percentile and weight-for-length percentile for 0-2 years; weight/age percentile, stature/age percentile and body mass index (BMI) percentile for 2-20 years; and BMI value for adults [21][22][23].…”

Evolución nutricional y función pulmonar en niños y adolescentes chilenos con fibrosis quística

“…Dicha recomendación se basa en que sobre p50 de IMC, el VEF 1 presenta un plateau superior a 80% y bajo p50 se deteriora, con mayor pendiente bajo p10 3 . Para adelantarse, se recomienda apoyo nutricional precoz y activo 10,11,24 , siendo importante explicar el défi cit y acordar con el paciente y su familia los plazos de respuesta, ya que en etapas avanzadas de la enfermedad se suman otros factores difíciles de revertir, los cuales agravan el deterioro pulmonar [25][26][27] . En adultos, se recomienda mantener un IMC mayor a 22 en mujeres y a 23 en hombres, puntos de corte asociados a un VEF 1  60% del predicho 11 .…”

Description of a Standardized Nutrition Classification Plan and its Relation to Nutritional Outcomes in Children with Cystic Fibrosis

“…However, these supplements have not been shown to consistently improve nutritional outcomes, especially when compared to behavioral interventions (Koretz, Avenell, Lipman, Braunschweig, & Milne, 2007;Smyth & Walters, 2007). Additionally, there are no randomized control trials to support the use of enteral feeding tubes in CF patients (Conway, Morton, & Wolfe, 2008). Appetite stimulants are also widely prescribed, but there are no large trials confirming their usefulness.…”

Enteral tube feeding for individuals with cystic fibrosis: Cystic Fibrosis Foundation evidence-informed guidelines

“…There are no randomized clinical trials to inform decisions regarding enteral tube feeding and CF, however, multiple retrospective studies suggest that its use can improve agedependent anthropometrics [7][8][9][10][11][12][13][14][15][16][17][18]20]. Age-dependent anthropometrics include weight/age percentile, length/age percentile and weight-for-length percentile for 0-2 years; weight/age percentile, stature/age percentile and body mass index (BMI) percentile for 2-20 years; and BMI value for adults [21][22][23].…”

Evolución nutricional y función pulmonar en niños y adolescentes chilenos con fibrosis quística

“…Dicha recomendación se basa en que sobre p50 de IMC, el VEF 1 presenta un plateau superior a 80% y bajo p50 se deteriora, con mayor pendiente bajo p10 3 . Para adelantarse, se recomienda apoyo nutricional precoz y activo 10,11,24 , siendo importante explicar el défi cit y acordar con el paciente y su familia los plazos de respuesta, ya que en etapas avanzadas de la enfermedad se suman otros factores difíciles de revertir, los cuales agravan el deterioro pulmonar [25][26][27] . En adultos, se recomienda mantener un IMC mayor a 22 en mujeres y a 23 en hombres, puntos de corte asociados a un VEF 1  60% del predicho 11 .…”

Description of a Standardized Nutrition Classification Plan and its Relation to Nutritional Outcomes in Children with Cystic Fibrosis

“…However, these supplements have not been shown to consistently improve nutritional outcomes, especially when compared to behavioral interventions (Koretz, Avenell, Lipman, Braunschweig, & Milne, 2007;Smyth & Walters, 2007). Additionally, there are no randomized control trials to support the use of enteral feeding tubes in CF patients (Conway, Morton, & Wolfe, 2008). Appetite stimulants are also widely prescribed, but there are no large trials confirming their usefulness.…”